158 related articles for article (PubMed ID: 37220289)
21. Paraneoplastic amyopathic dermatomyositis associated with breast cancer recurrence.
Goyal S; Nousari HC
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):874-5. PubMed ID: 10534675
[TBL] [Abstract][Full Text] [Related]
22. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
[TBL] [Abstract][Full Text] [Related]
23. SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report.
Arnon J; Elia A; Nevo Y; Lossos A; Nechushtan H
JTO Clin Res Rep; 2021 Sep; 2(9):100217. PubMed ID: 34590056
[TBL] [Abstract][Full Text] [Related]
24. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
[TBL] [Abstract][Full Text] [Related]
25. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
[TBL] [Abstract][Full Text] [Related]
28. Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen.
De Vooght J; Vulsteke JB; De Haes P; Bossuyt X; Lories R; De Langhe E
Rheumatology (Oxford); 2020 Mar; 59(3):469-477. PubMed ID: 31883334
[TBL] [Abstract][Full Text] [Related]
29. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement.
Rodríguez-Tejero A; López-Espadafor B; Montero-Vílchez T; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A
Dermatol Ther; 2021 May; 34(3):e14942. PubMed ID: 33719170
[TBL] [Abstract][Full Text] [Related]
30. Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site.
Hori H; Ozeki Y; Kobashigawa T; Futsuhara K; Tanaka A; Watanabe E; Yabe H; Yago T; Fukuchi T; Sugawara H; Kotake S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):62-68. PubMed ID: 33269651
[TBL] [Abstract][Full Text] [Related]
31. A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody".
Koizumi H; Muro Y; Imai S; Yamashita Y; Ogawa-Momohara M; Takeichi T; Murakami M; Mitsuma T; Akiyama M
J Dermatol; 2023 Jan; 50(1):e39-e40. PubMed ID: 36176040
[No Abstract] [Full Text] [Related]
32. Amyopathic dermatomyositis: definitions, diagnosis, and management.
Bailey EE; Fiorentino DF
Curr Rheumatol Rep; 2014 Dec; 16(12):465. PubMed ID: 25366932
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
[TBL] [Abstract][Full Text] [Related]
34. How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic?
Oberle EJ; Bayer ML; Chiu YE; Co DO
Pediatr Dermatol; 2017 Jan; 34(1):50-57. PubMed ID: 27813167
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics of patients with anti-TIF1-γ antibodies.
Masiak A; Kulczycka J; Czuszyńska Z; Zdrojewski Z
Reumatologia; 2016; 54(1):14-8. PubMed ID: 27407271
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.
Fiorentino DF; Mecoli CA; Rosen MC; Chung LS; Christopher-Stine L; Rosen A; Casciola-Rosen L
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 35040440
[TBL] [Abstract][Full Text] [Related]
37. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.
Cao H; Parikh TN; Zheng J
Clin Rheumatol; 2009 Aug; 28(8):979-84. PubMed ID: 19294477
[TBL] [Abstract][Full Text] [Related]
38. Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.
Callander J; Robson Y; Ingram J; Piguet V
Br J Dermatol; 2018 Dec; 179(6):1248-1255. PubMed ID: 27167896
[TBL] [Abstract][Full Text] [Related]
39. Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis.
Li X; Huang Y; Liu Y; Yan S; Li L; Cheng L; Li H; Zhan H; Zhang F; Li Y
Clin Rheumatol; 2023 Mar; 42(3):817-830. PubMed ID: 36357631
[TBL] [Abstract][Full Text] [Related]
40. [Regression of primary melanoma with metastases associated with amyopathic dermatomyositis].
Villers A; Lami MC; Filoche P; Milinkevitch S; Goujon JM; Guillet G
Ann Dermatol Venereol; 2006; 133(6-7):573-6. PubMed ID: 16885848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
